Stock HORIZON PHARMA INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Horizon Pharma Inc Nasdaq

Equities

US44047T1097

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Horizon Pharma Inc
16/01 Health Canada Approves Horizon Therapeutics plc 's UPLIZNA® (inebilizumab for injection) for the Treatment of Neuromyelitis Optica Spectrum Disorders CI
2023 Global markets live: Boeing, Amgen, Microsoft, Volkswagen, Tesla... Our Logo

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Health Canada Approves Horizon Therapeutics plc 's UPLIZNA® (inebilizumab for injection) for the Treatment of Neuromyelitis Optica Spectrum Disorders
CI
Global markets live: Boeing, Amgen, Microsoft, Volkswagen, Tesla...
Our Logo
AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC
AQ
Horizon Therapeutics Public Limited Company Announces the Cessation of Member of the Board of Directors
CI
Rule 17(d) Announcement, Horizon Therapeutics plc
AQ
Amgen completes $27.8 bln Horizon deal
RE
Amgen Completes Acquisition of Horizon Therapeutics
MT
Amgen completes acquisition of Horizon Therapeutics
RE
Rule 17(e) Announcement - Horizon Therapeutics plc
BU
Horizon Therapeutics Public Limited Company(NasdaqGS:HZNP) dropped from NASDAQ Composite Index
CI
Horizon Therapeutics Public Limited Company(NasdaqGS:HZNP) dropped from FTSE All-World Index
CI
Horizon Therapeutics Public Limited Company(NasdaqGS:HZNP) dropped from S&P Global BMI Index
CI
Horizon Therapeutics Public Limited Company(NasdaqGS:HZNP) dropped from S&P TMI Index
CI
Horizon Therapeutics Public Limited Company(NasdaqGS:HZNP) dropped from S&P Biotechnology Select Industry Index
CI
Horizon Therapeutics Public Limited Company's Equity Buyback announced on September 9, 2022, has expired.
CI
Amgen Inc. completed the acquisition of Horizon Therapeutics Public Limited Company.
CI
Amgen Wins Irish Court Approval to Acquire Horizon Therapeutics
MT
Rule 17(d) Announcement – Horizon Therapeutics plc
BU
Horizon Therapeutics Public Limited Company(NasdaqGS:HZNP) dropped from NASDAQ Biotechnology Index
CI
Rule 8.1 Dealing Disclosure (Horizon Therapeutics plc)
BU
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. HZNP Stock
  4. Stock
  5. News Horizon Pharma Inc
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW